Singapore markets open in 7 hours 28 minutes
  • Straits Times Index

    3,191.16
    +25.98 (+0.82%)
     
  • S&P 500

    4,031.92
    +8.03 (+0.20%)
     
  • Dow

    32,403.84
    +207.18 (+0.64%)
     
  • Nasdaq

    11,748.23
    -56.77 (-0.48%)
     
  • BTC-USD

    29,647.94
    -526.66 (-1.75%)
     
  • CMC Crypto 200

    664.18
    +421.50 (+173.69%)
     
  • FTSE 100

    7,464.80
    +46.65 (+0.63%)
     
  • Gold

    1,813.80
    +5.60 (+0.31%)
     
  • Crude Oil

    113.40
    +2.91 (+2.63%)
     
  • 10-Yr Bond

    2.8790
    -0.0560 (-1.91%)
     
  • Nikkei

    26,547.05
    +119.40 (+0.45%)
     
  • Hang Seng

    19,950.21
    +51.44 (+0.26%)
     
  • FTSE Bursa Malaysia

    1,544.41
    +5.61 (+0.36%)
     
  • Jakarta Composite Index

    6,597.99
    -1.85 (-0.03%)
     
  • PSE Index

    6,502.12
    +122.95 (+1.93%)
     

$13+ Billion Worldwide Cell Culture Consumables and Equipment Industry to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com

·4-min read

DUBLIN, November 10, 2021--(BUSINESS WIRE)--The "Cell Culture Consumables and Equipment Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering.

This report provides strategists, marketers and senior management with the critical information they need to assess the global cell culture consumables and equipment market.

The global cell culture consumables and equipment market is expected to grow from $8.55 billion in 2020 to $9.46 billion in 2021 at a compound annual growth rate (CAGR) of 10.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $13.49 billion in 2025 at a CAGR of 9.3%.

Companies Mentioned

  • Becton Dickinson

  • Corning Incorporation

  • Eppendorf

  • GE Healthcare

  • Merck KGaA

  • Thermo Fisher Scientific

  • Lonza

  • HiMedia Laboratories

  • Agilent Technologies

  • PromoCell GmbH

  • CellGenix GmbH

  • InvivoGen

  • Greiner Bio-One

  • Irvine Scientific

  • Cell Culture Company (CCC) LLC

  • Sera Care Life Sciences Incorporation

  • American Type Culture Collection

  • Miltenyi Biotec

  • AITbiotech

  • ESSEN

  • Sigma-Aldrich

  • Bel-Art

  • MilliporeSigma

  • Cellgenix

  • Sumitomo Bakelite

  • EMD Millipore

  • Affymetrix Inc

  • VWR International

  • LLC

  • WHEATON IndustriesInc

  • Sartorius AG

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.

  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.

  • Create regional and country strategies on the basis of local data and analysis.

  • Identify growth segments for investment.

  • Outperform competitors using forecast data and the drivers and trends shaping the market.

  • Understand customers based on the latest market research findings.

  • Benchmark performance against key competitors.

  • Utilize the relationships between key data sets for superior strategizing.

  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The cell culture consumables and equipment global market consists of sales of cell culture consumables, equipment and related service. Cell culture consumables include sera, media, reagents, and equipment such as bioreactors, cell counters, filtration systems, centrifuges, and incubators. The services includes only installation and maintenance services offered by equipment manufacturers. Cell culture consumables and equipment are designed to aid scientist in growing new cells in the culture media for drug development, tissue culture, and engineering, gene therapy, vaccine production and toxicity testing.

The cell culture consumables and equipment market covered in this report is segmented by product into consumables, instruments. It is also segmented by end user into industrial, biotechnology, agriculture, others; by application into vaccination, toxicity testing, cancer research, drug screening and development, recombinant products, stem cell technology, regenerative medicine, others; by consumables into media, sera, reagents and by instruments into cell culture vessels, bioreactors, biosafety cabinets, carbon dioxide incubators, centrifuges.

Contamination of cell culture is the most prominent factor restricting the growth of cell culture consumables and equipment market. Contaminated culture is the presence of non-living substances or unwanted foreign microorganisms that have undesirable effects on the cell culture. Using contaminated culture cells has a number of negative consequences on the users and thus hampers the growth of this market. For example, an article published on MedCrave, stated that Mycloplasma is one of the most common and difficult to detect contaminants. The article also highlighted the results of a study on fibroblasts and keratinocyte cell lines that showed 32.35% of contamination, out of which 17.65% were mycoplasma contaminated cultures, followed by fungal (8.82%) and bacterial (5.88%) contaminants. Hence, the high risk associated with cell culture techniques pose a threat to the growth of cell culture consumables and equipment market.

Companies in cell culture consumables and equipment are investing more in 3D cell culture for its new and advantageous features. 3D cell culture may be defined as the culture of living cells within micro-assembled devices and supports that present a three dimensional structure and are used to replicate a tissue or an organ in an artificial environment by allowing the cells to interact with the surroundings in all three directions. 3D cell cultures are more relevant with higher degree of structural complexity and maintains the steady state for more time as compared to 2D cell cultures. Visikol launched OpenLiver 3D cell culture models in January 2019 to enter into 3D cell culture technology.

The countries covered in the market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

For more information about this report visit https://www.researchandmarkets.com/r/axq64c

View source version on businesswire.com: https://www.businesswire.com/news/home/20211110005934/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting